NO911174L - Kermesbaer antiviralt protein (pap)-monoklonalt antistoffkonjugat. - Google Patents

Kermesbaer antiviralt protein (pap)-monoklonalt antistoffkonjugat.

Info

Publication number
NO911174L
NO911174L NO91911174A NO911174A NO911174L NO 911174 L NO911174 L NO 911174L NO 91911174 A NO91911174 A NO 91911174A NO 911174 A NO911174 A NO 911174A NO 911174 L NO911174 L NO 911174L
Authority
NO
Norway
Prior art keywords
pap
monoclonal antibody
kermesbaer
antiviral protein
antibody conjugate
Prior art date
Application number
NO91911174A
Other languages
English (en)
Norwegian (no)
Other versions
NO911174D0 (no
Inventor
Fatih M Uckun
Joyce M Zarling
Original Assignee
Univ Minnesota
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Oncogen filed Critical Univ Minnesota
Publication of NO911174D0 publication Critical patent/NO911174D0/no
Publication of NO911174L publication Critical patent/NO911174L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO91911174A 1989-07-25 1991-03-22 Kermesbaer antiviralt protein (pap)-monoklonalt antistoffkonjugat. NO911174L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38531489A 1989-07-25 1989-07-25
US50352290A 1990-03-30 1990-03-30
PCT/US1990/003921 WO1991001145A1 (fr) 1989-07-25 1990-07-12 Conjugues de proteines antivirales pokeweed - anticorps monoclonaux

Publications (2)

Publication Number Publication Date
NO911174D0 NO911174D0 (no) 1991-03-22
NO911174L true NO911174L (no) 1991-05-24

Family

ID=27010961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911174A NO911174L (no) 1989-07-25 1991-03-22 Kermesbaer antiviralt protein (pap)-monoklonalt antistoffkonjugat.

Country Status (17)

Country Link
EP (1) EP0441917B1 (fr)
JP (1) JP3109678B2 (fr)
KR (1) KR920700698A (fr)
AT (1) ATE137410T1 (fr)
AU (1) AU631674B2 (fr)
CA (1) CA2037900C (fr)
DE (1) DE69026812T2 (fr)
DK (1) DK0441917T3 (fr)
ES (1) ES2087158T3 (fr)
FI (1) FI911447A7 (fr)
GR (1) GR1002180B (fr)
IE (1) IE74143B1 (fr)
IL (1) IL95134A (fr)
NO (1) NO911174L (fr)
NZ (1) NZ234607A (fr)
PT (1) PT94789B (fr)
WO (1) WO1991001145A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0425604U (fr) * 1990-06-27 1992-02-28
GB9217124D0 (en) * 1992-08-13 1992-09-23 Antisoma Ltd Medical treatment
US6576236B1 (en) * 1994-07-01 2003-06-10 Dana Farber Cancer Institute Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
US5919457A (en) * 1996-01-11 1999-07-06 Regents Of The University Of Minnesota TXU-5/B53-PAP antiviral biotherapeutic agent for the treatment of AIDS
AU2012241894B2 (en) 2011-04-12 2015-12-03 Novo Nordisk A/S Double-acylated GLP-1 derivatives

Also Published As

Publication number Publication date
FI911447A0 (fi) 1991-03-25
IL95134A (en) 1996-01-31
ES2087158T3 (es) 1996-07-16
KR920700698A (ko) 1992-08-10
EP0441917B1 (fr) 1996-05-01
AU631674B2 (en) 1992-12-03
GR1002180B (en) 1996-03-11
CA2037900A1 (fr) 1991-01-26
IE74143B1 (en) 1997-07-02
ATE137410T1 (de) 1996-05-15
DE69026812T2 (de) 1996-11-28
NO911174D0 (no) 1991-03-22
JPH04502625A (ja) 1992-05-14
IL95134A0 (en) 1991-06-10
GR900100550A (el) 1991-12-10
WO1991001145A1 (fr) 1991-02-07
AU6140590A (en) 1991-02-22
DK0441917T3 (da) 1996-09-16
CA2037900C (fr) 1999-11-16
EP0441917A1 (fr) 1991-08-21
FI911447A7 (fi) 1991-03-25
JP3109678B2 (ja) 2000-11-20
IE902593A1 (en) 1991-02-27
PT94789A (pt) 1991-03-20
NZ234607A (en) 1992-10-28
DE69026812D1 (de) 1996-06-05
PT94789B (pt) 1997-04-30

Similar Documents

Publication Publication Date Title
SE9301270D0 (sv) Biosensor
DK228486A (da) Retrovirale polypeptider med tilknytning til human celletransformation
MY104946A (en) Antigen antibody conjugate.
DE68922385D1 (de) Neuer monoklonaler Antikörper gegen menschliches Karzinom.
ES2045216T3 (es) Inmunoensayo y derivados polimeros de igg para la compensacion de factores de perturbacion en el inmunoensayo.
PT78885B (pt) Schiebeschalter
NO911174D0 (no) Kermesbaer antiviralt protein (pap)-monoklonalt antistoffkonjugat.
ATE76877T1 (de) Hapten-protein-konjugate und ihre verwendung.
FI880636L (fi) Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter.
AU576088B2 (en) Histamine derivatives, immunogen conjugates and antibodies raised thereto
DK0752102T3 (da) Immunoenzymatisk konjugat, fremgangsmåde til fremstilling af konjugatet og anvendelse af dette.
AU6257486A (en) Specific mycoplasma membrane antigen and antibody and their clinical applications
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
FI841094A7 (fi) Kantajaan sidottu virusantigeeni, sen valmistus ja käyttö.
ATE85215T1 (de) Antivirales therapeutikum.
White Fresnoite ceramics and thin films.
AU2624288A (en) Hiv peptides, artificial hiv antigens and immunoassay kits
ITPG910012U1 (it) Bavaglio monouso
IT8619509A0 (it) Bruciatore per combustibili poco reattivi.
IT8522274A0 (it) Bruciatore per combustibili poco reattivi.
NO880302D0 (no) Fluorescens-immunoanalyse innbefattende energioverfoering mellom to fluoroforer.
ES292276U (es) Dispositivo perfeccionado de aprovechamiento calorico
KR880008098A (ko) 광합성 시계
ITPN910035U1 (it) Banco per stiratura per uso domestico